| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999452 | Urologic Oncology: Seminars and Original Investigations | 2015 | 6 Pages |
Abstract
MRI-TRUS FGB with cognitive assistance is able to detect and diagnose locally recurrent lesions after RP, even at low PSA levels. This may facilitate early detection of recurrent disease and improve salvage treatment outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Berrend G. M.D., Aradhana M.D., Sandeep M.D., Elena B.S., Anthony N. M.D., Arvin K. M.D., Soroush M.D., Jochen Ph.D., Pingkun Ph.D., Sheng Ph.D., Jean J. M.D., Ph.D., Maria J. M.D., Bradford J. M.D., Peter A. M.D., Peter L. M.D., Baris M.D.,